EP Patent

EP0167919A2 — Benzodiazepine derivatives and pharmaceutical compositions containing them

Assigned to Merck and Co Inc · Expires 1986-01-15 · 40y expired

What this patent protects

Benzodiazepine analogs of the formula: <CHEM> are disclosed which are antagonists of cholecystokinin (CCK). h

USPTO Abstract

Benzodiazepine analogs of the formula: <CHEM> are disclosed which are antagonists of cholecystokinin (CCK). h

Drugs covered by this patent

remimazolam-besylate (REMIMAZOLAM BESYLATE)

Patent Metadata

Patent number: EP0167919A2
Jurisdiction: EP
Classification: —
Expires: 1986-01-15
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.